Get the app
US › Healthcare

Aspire BioPharma, Inc. (ASBP)

US · Healthcare · Biotechnology

$9.12+6.29%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$63,103
Net profit
$-1.3M
EPS
$1.00
Net margin
-2,009.6%

Key statistics

Market cap
$12.8M
Forward P/E
0.0
P/B
1.06
Book value
$9.08
EPS (TTM)
$-6.91
52-week high
$562.92
52-week low
$3.31
50-day MA
$7.27
200-day MA
$3.99
Beta
0.17

Shareholding

Insiders
20.10%
Institutions
3.36%

Largest institutional holders

FundStake
UBS Group AG0.49%
Morgan Stanley - Brokerage Accounts0.20%
Geode Capital Management, LLC0.11%
Crewe Advisors LLC0.05%
Vanguard Capital Management, LLC0.02%
Vanguard Fiduciary Trust Co0.01%
Tower Research Capital LLC0.01%
Citigroup Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Aspire BioPharma, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.